Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 42
1947 64
1948 134
1949 115
1950 95
1951 105
1952 112
1953 102
1954 105
1955 112
1956 96
1957 104
1958 100
1959 110
1960 142
1961 109
1962 105
1963 125
1964 129
1965 158
1966 155
1967 152
1968 166
1969 157
1970 183
1971 151
1972 178
1973 187
1974 184
1975 183
1976 217
1977 243
1978 273
1979 302
1980 365
1981 371
1982 421
1983 391
1984 430
1985 492
1986 521
1987 608
1988 630
1989 753
1990 763
1991 888
1992 965
1993 1021
1994 1108
1995 1135
1996 1288
1997 1207
1998 1232
1999 1093
2000 1245
2001 1187
2002 1893
2003 1902
2004 1731
2005 1755
2006 1690
2007 1709
2008 1882
2009 1971
2010 1951
2011 2178
2012 1801
2013 1565
2014 1492
2015 1269
2016 1265
2017 1155
2018 987
2019 787
2020 853
2021 947
2022 919
2023 828
2024 848
2025 926
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52,626 results

Results by year

Filters applied: . Clear all
Page 1
Acalabrutinib-obinutuzumab improves survival vs chemoimmunotherapy in treatment-naive CLL in the 6-year follow-up of ELEVATE-TN.
Sharman JP, Egyed M, Jurczak W, Skarbnik A, Patel K, Flinn IW, Kamdar M, Munir T, Walewska R, Hughes M, Fogliatto LM, Herishanu Y, Banerji V, Follows G, Walker P, Ghia P, Janssens A, Byrd JC, Ferrant E, Ferrajoli A, Wierda WG, Wachira CW, Suterwala BT, Miranda P, Munugalavadla V, Wun CC, Woyach JA. Sharman JP, et al. Blood. 2025 Sep 11;146(11):1276-1285. doi: 10.1182/blood.2024024476. Blood. 2025. PMID: 40198878 Free article. Clinical Trial.
Driving CAR-Ts SafeSLE.
Bonifant CL, Shah NN. Bonifant CL, et al. Blood. 2025 Aug 28;146(9):1034-1035. doi: 10.1182/blood.2025030096. Blood. 2025. PMID: 40875552 No abstract available.
Thrombophilic thrombomodulin variants.
Castoldi E. Castoldi E. Blood. 2025 Apr 24;145(17):1837-1839. doi: 10.1182/blood.2024027934. Blood. 2025. PMID: 40272857 No abstract available.
LocaTIAN, locaTIAN, locaTIAN.
Gust J, Schultz LM. Gust J, et al. Blood. 2025 Oct 16;146(16):1871-1872. doi: 10.1182/blood.2025030292. Blood. 2025. PMID: 41100145 No abstract available.
Richter transformation recommendations.
Sander B. Sander B. Blood. 2025 Jul 17;146(3):262-263. doi: 10.1182/blood.2025029450. Blood. 2025. PMID: 40674115 No abstract available.
Daratumumab-bortezomib-thalidomide-dexamethasone for newly diagnosed myeloma: CASSIOPEIA minimal residual disease results.
Corre J, Vincent L, Moreau P, Hebraud B, Hulin C, Béné MC, Broijl A, Caillot D, Delforge M, Dejoie T, Facon T, Lambert J, Leleu X, Macro M, Perrot A, Zweegman S, Filleron T, Cabarrou B, van de Donk NWCJ, Mahéo S, Hua W, Wang J, Krevvata M, Vanquickelberghe V, de Boer C, Tuozzo A, Borgsten F, Rowe M, Carson R, Wuilleme S, Sonneveld P. Corre J, et al. Blood. 2025 Aug 7;146(6):679-692. doi: 10.1182/blood.2024027620. Blood. 2025. PMID: 40127397 Clinical Trial.
52,626 results
You have reached the last available page of results. Please see the User Guide for more information.